Other High-risk Hematological Malignancies
1 clinical trials · Condition
◉ Watch Other High-risk Hematological Malignancies
| Record | Firm | Date |
|---|---|---|
| Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT (NCT02786485) | Bellicum Pharmaceuticals | 2016-05-01 |
Track Other High-risk Hematological Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.